DDX19A-DT: A Promising Drug Target / Biomarker (G100506083)

Target Name: DDX19A-DT

NCBI ID: G100506083

DDX19A-DT

Other Name(s): DDX19A divergent transcript

DDX19A-DT: A Promising Drug Target / Biomarker

The protein known as DDX19A-DT is a potential drug target (also known as a biomarker) that is being studied for its role in various diseases, including cancer.DDX19A-DT is a transmembrane protein that is expressed in many different tissues and cells in the body. It is involved in a number of different processes in the cell, including cell signaling, DNA replication, and apoptosis.

One of the key functions of DDX19A-DT is its role in the regulation of cell apoptosis. Apoptosis, or cell death, is a natural and important process that helps the body remove damaged or dysfunctional cells. However, when apoptosis is triggered by harmful factors, such as cancer cells, it can lead to the development of diseases such as cancer.

Research has shown that DDX19A-DT plays a key role in the regulation of apoptosis in cancer cells. In fact, studies have shown that inhibiting the activity of DDX19A-DT has been shown to increase the sensitivity of cancer cells to chemotherapy. This suggests that DDX19A-DT may be an effective target for cancer treatments.

Another function of DDX19A-DT is its role in cell signaling. Signal transduction is the process by which cells respond to signals from the environment.DDX19A-DT is involved in a number of different signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and apoptosis, among other things.

Research has also shown that DDX19A-DT is involved in the regulation of cell cycle progression. The cell cycle is the process by which cells grow, divide, and replicate their genetic material.DDX19A-DT is involved in the regulation of cell cycle progression, which is important for the development and progression of cancer.

In addition to its role in cell signaling and apoptosis, DDX19A-DT is also involved in the regulation of DNA replication. DNA replication is the process by which a cell makes a copy of its genetic material.DDX19A-DT is involved in the regulation of DNA replication, which is important for the growth and development of cancer cells.

DDX19A-DT is also involved in the regulation of cell adhesion. Cell adhesion is the process by which cells stick together and form tissues.DDX19A-DT is involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs.

Conclusion

In conclusion, the protein known as DDX19A-DT is involved in a number of different processes in the cell, including cell signaling, DNA replication, apoptosis, and cell cycle progression. It is also involved in the regulation of cell adhesion. As a potential drug target, DDX19A-DT has the potential to be an effective target for cancer treatments. Further research is needed to fully understand its role and potential as a drug target.

Protein Name: DDX19A Divergent Transcript

The "DDX19A-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DDX19A-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets